This track explores the intricate connections between immune responses and metabolic processes. It aims to highlight how immunometabolic interactions influence health and disease outcomes.

This session focuses on the role of chronic inflammation in the development and progression of cardiometabolic diseases. Discussions will center on mechanisms linking inflammatory pathways to metabolic dysregulation.

This track delves into the signaling pathways utilized by immune cells that regulate metabolic functions. It seeks to uncover how these pathways contribute to the pathophysiology of metabolic disorders.

This session addresses the immunological factors contributing to the pathogenesis of metabolic syndrome. It aims to provide insights into potential therapeutic targets for intervention.

This track investigates the interplay between immune responses and cardiovascular health. It will explore how immune-metabolic interactions can inform new strategies for preventing and treating cardiovascular diseases.

This session highlights the latest advancements in translational research bridging basic immunometabolism and clinical applications. It aims to showcase innovative approaches to translate findings into therapeutic interventions.

This track examines the influence of gut microbiota on immune and metabolic health. Discussions will focus on how microbial interactions can modulate immune responses and metabolic pathways.

This session explores novel therapeutic strategies aimed at modulating immune metabolism for the treatment of cardiometabolic diseases. It will cover both pharmacological and lifestyle interventions.

This track investigates how metabolic disorders affect immune regulation and vice versa. It aims to elucidate the bidirectional relationship between metabolism and immune function.

This session focuses on identifying and validating biomarkers associated with immunometabolic diseases. It aims to enhance our understanding of disease mechanisms and improve diagnostic accuracy.

This track will discuss the future landscape of immunometabolic research, highlighting emerging trends and technologies. It aims to foster collaboration and innovation in addressing cardiometabolic diseases.